Skip to main content

Table 1 Clinical characteristics of patients

From: Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS

 

Normal (n = 30)

PCOS (n = 30)

P-value

Age (years)

33.6 ± 2.2

32.6 ± 3.1

NS

BMI (kg/m2)

21.4 ± 1.6

21.6 ± 1.5

NS

FSH (mIU/ml)

6.51 ± 1.2

5.41 ± 1.3

< 0.05

LH (mIU/ml)

4.30 ± 1.4

11.91 ± 2.6

< 0.001

Basal LH/FSH

0.65 ± 0.2

2.52 ± 0.61

< 0.001

E2 (pg/ml)

38.5 ± 4.3

41.3 ± 9.5

NS

Testosterone (ng/ml)

0.12 ± 0.05

0.68 ± 0.05

< 0.001

Progesterone (ng/ml)

0.55 ± 0.22

0.70 ± 0.23

NS

Antral follicle count

10.2 ± 1.1

24.1 ± 3.7

< 0.001

Oocytes obtained

8.5 ± 3.0

17.8 ± 5.2

< 0.001

No of MII oocytes

6.3 ± 1.8

14.5 ± 4.6

< 0.001

  1. Data are the mean ± SEM, NS not statistically significant
  2. BMI body mass index, E2 oestradiol, FSH follicle-stimulating hormone, LH luteotropic hormone, PCOS polycystic ovary syndrome
Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us